Insights from Fall Clinical

Roger I. Ceilley, MD, presented on surgical tips at the 2019 Fall Clinical Dermatology Conference.

Dawn Sammons, DO, discussed some of the common beliefs patients and providers have at the 2019 Fall Clinical Dermatology Conference.

The luxury skin care market is one of the largest and fast-growing markets. Hilary E. Baldwin, MD, discussed what dermatologists need to know about cosmeceuticals in order to counsel patients on products.

At the 2019 Fall Clinical Dermatology Conference, David E. Cohen, MD, discussed current trends in contact dermatitis, including the 2020 “Allergen of the Year.”

Adam Friedman, MD, discussed options for treating warts at the 2019 Fall Clinical Dermatology Conference.

Botulinum toxins continue to be a popular treatment option for cosmetic patients. At the 2019 Fall Clinical Dermatology Conference, Neil Sadick, MD, presented on off label uses of botulinum toxins, including for aging prophylaxis and treatment of scars.

Boni E. Elewski, MD, and David M. Pariser, MD, presented on strategies for psoriasis, including selecting biologics and how to incorporate patient’s goals into treatment plans.

At the 2019 Fall Clinical Dermatology Conference, Joslyn Kirby, MD, discussed the management of hidradenitis suppurativa, as well as new therapies being developed for this devastating disease.

Zoe Draelos, MD, presented on the latest evidence for optimizing post-procedural care following in-office dermatology procedures at the 2019 Fall Clinical Dermatology Conference.

Gil Yosipovitch, MD, discussed the latest developments in pruritus therapies at the 2019 Fall Clinical Dermatology Conference.